|
Our approach to curing MS: Complex diseases call for innovative approaches. Our approach is the MS Repository, a biobank of blood samples and data from people with MS and matched controls. Like most biobanks, we make these samples and data available to scientists investigating MS and other demyelinating diseases. Unlike most biobanks, we take the extra step of collecting research results from scientists using our samples so that they can be analyzed together. Our vision is that harnessing together the power of this data will enable important breakthroughs: treatments, prevention strategies, and ultimately cures for MS.
Building bridges: Curing MS requires communication and collaboration. We host annual scientific symposia, post conference notes and study summaries on our MSNews portal, and are working with the MassGeneral Institute for Neurodegenerative Disease (MIND) to develop an on-line community to spark discussion and ideas among MS scientists. We have built strong partnerships with the Guthy-Jackson Charitable Foundation and the Transverse Myelitis Association that support research into other demyelinating diseases through the repository. We also hold events where members of the MS community can meet and learn from each other.
Our impact to date: The MS Repository includes samples and data from over 2,700 subjects. These samples and data have supported over 50 research studies aimed at creating new treatments, better diagnostic methods, and strategies for preventing MS. Our repository of research data includes 18 data sets containing over 152 million data points that are contributing to a more comprehensive understanding of MS.
Get involved: We invite you to make a donation, participate in one of our events, sign up for our newsletter and mailing lists, and enroll in the MS Repository. We also hope you will learn more about us and the impact we're having on MS research.
Our organization is transparent and accountable with your donations. We have received a four-star rating from Charity Navigator. Click here to see our GuideStar Report.
|
|
